GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RPG Life Sciences Ltd (BOM:532983) » Definitions » Change In Receivables

RPG Life Sciences (BOM:532983) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is RPG Life Sciences Change In Receivables?

RPG Life Sciences's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means RPG Life Sciences's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

RPG Life Sciences's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-357 Mil. It means RPG Life Sciences's Accounts Receivable increased by ₹357 Mil from Mar. 2024 to Mar. 2025 .

RPG Life Sciences's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹868 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. RPG Life Sciences's Days Sales Outstanding for the three months ended in Mar. 2025 was 55.33.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. RPG Life Sciences's liquidation value for the three months ended in Mar. 2025 was ₹2,556 Mil.


RPG Life Sciences Change In Receivables Historical Data

The historical data trend for RPG Life Sciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RPG Life Sciences Change In Receivables Chart

RPG Life Sciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.20 247.10 -54.80 -142.30 -357.30

RPG Life Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

RPG Life Sciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RPG Life Sciences  (BOM:532983) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

RPG Life Sciences's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=867.6/1430.9*91
=55.33

2. In Ben Graham's calculation of liquidation value, RPG Life Sciences's accounts receivable are only considered to be worth 75% of book value:

RPG Life Sciences's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2713-1272.8+0.75 * 867.6+0.5 * 929.8
=2,556

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RPG Life Sciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of RPG Life Sciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


RPG Life Sciences Business Description

Traded in Other Exchanges
Address
463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.

RPG Life Sciences Headlines

No Headlines